In addition, NKILA has also been shown to inhibit tumor invasion and migration in epithelial cancers, such as breast cancer, hepatocellular carcinoma and tongue squamous cell carcinoma [19,39,40]. The gene discussed is NKILA; the disease is hepatocellular carcinoma.